By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Finance > Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more

Last updated: March 10, 2026 5:24 pm
8 hours ago
Share
SHARE


Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience store chain shed 2.6% following its third-quarter revenue miss. Casey’s General Stores reported revenue of $3.92 billion, short of the $4.04 billion consensus estimate, per FactSet. Earnings, however, topped expectations. Taiwan Semiconductor — The Taiwanese chipmaker’s shares inched up about 1% in premarket after the company reported a 30% increase in sales over the first two months of the year. Vail Resorts — The ski resort’s stock price slid 1.1% after reporting earnings of $5.87 per share on $1.08 billion in revenue, while analysts polled by LSEG expected $6.10 per share on $1.11 billion in revenue. The company also lowered its guidance “due to the persistent, historically challenging weather conditions in the Rockies.” Hewlett Packard Enterprise — Shares of the technology company rose 1%. HPE earned 65 cents per share, on an adjusted basis, for its first quarter. That exceeded analysts’ estimate of 59 cents per share, according to LSEG. The company’s $9.30 billion in revenue fell slightly short of the $9.33 billion expected, meanwhile. Vertex Pharmaceuticals — Vertex Pharmaceuticals shares advanced more than 6% after the biotech company said its drug met its goals in a late-stage trial for IgA nephropathy, a chronic condition that can lead to kidney failure. — CNBC’s Michelle Fox, Yun Li and Pia Singh contributed reporting



Source link

You Might Also Like

Kevin Warsh faces an economic ‘perfect storm’ as he waits to take over as Fed chair

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Gas prices pass $3.50 per gallon to highest level since 2024 amid U.S.-Iran war

Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’

Fears of 1970s-style stagflation arise with oil spike to $100. How big a threat is it?

TAGGED:Breaking News: MarketsBusinessBusiness NewsCasey's General Stores IncDividendsEconomyHewlett Packard Enterprise CoiShares Biotechnology ETFiShares Semiconductor ETFiShares U.S. Technology ETFKohls CorpMarket InsiderMarketsregwall-proSpdr S&P Biotech EtfStock marketsTaiwan Semiconductor Manufacturing Co LtdTechnology Select Sector SPDR FundVail Resorts IncVertex Pharmaceuticals Inc
Share This Article
Facebook Twitter Email Print
Previous Article Silver rate jumps more than 4% on MCX, touches ₹2.8 lakh— Is it the right time to buy the white metal? | Stock Market News
Next Article Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS